Approval · Notice of Compliance 22727 · 2019
DOLMECTIN: Notice of Compliance 22727
Issued September 30, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22727
- Date
- September 30, 2019
- Company
- Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Canadian reference product
- REVOLUTION (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOLMECTIN | 02491206 | Dormant |
Medicinal ingredients
- SELAMECTIN 60 MG per 0.5ML